Riskpilot← Back to searchSign inGet full accessAPOTEK 1 DVERGSNES AS
ASActiveOrg 927587548Moltestien 3, 4634 Kristiansand SRetail sale of pharmaceutical products · NACE 4773Est. 20216 employees
Revenue 2025
NOK 17,7M
+28% vs 2024
EBITDA margin
3.0%
+1181% vs 2024
Equity ratio
-4.7%
Financial strength
Net profit 2025
NOK 210K
+162% vs 2024
| Revenue | NOK 17,7M | +28% |
| EBITDA | NOK 525K | +1181% |
| Net profit | NOK 210K | +162% |
| Total assets | NOK 4,3M | +9% |
| Equity | NOK -204K | +51% |
| Employees | 6 | — |
Legal name
APOTEK 1 DVERGSNES AS
Org number
927587548
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
25. august 2021
Share capital
NOK 50 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Butikkhandel med apotekvarer. Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette. Kjøp, salg og investering i eiendom. Kjøp, salg og investering i aksjer. Samt alt hva som herved står i forbindelse, herunder å delta i andre selskaper med lignende virksomhet.
Address
Moltestien 3, 4634 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 804 | 13 829 | 17 728 |
| Staff expenses | −0 | −0 | −223 | −2 679 | −2 873 |
| EBITDA | −0 | 0 | −121 | −49 | 525 |
| Depreciation & amort. | −0 | −0 | −12 | −147 | −148 |
| EBIT | −0 | 0 | −132 | −195 | 377 |
| Net financials | 0 | 0 | −20 | −238 | −107 |
| Profit before tax | −0 | 0 | −152 | −433 | 270 |
| Tax | −0 | −0 | −35 | −94 | 59 |
| Net profit | −0 | 0 | −117 | −340 | 210 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 43 | 43 | 4 956 | 3 968 | 4 323 |
| Equity | 43 | 43 | −75 | −414 | −204 |
| Long-term debt | 0 | 0 | 2 500 | 2 502 | 0 |
| Short-term debt | 0 | 0 | 2 531 | 1 880 | 2 401 |
| Total debt | 0 | 0 | 5 031 | 4 382 | 4 527 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20212025
Equity ratio
-4.7%
This company
38.2%
Market median
-112% vs market
20212025
Return on equity
21022400.0%
This company
18.4%
Market median
+114252074% vs market
20212025
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20212025
Asset turnover
4.10×
This company
1.12×
Market median
+266% vs market
20212025
Debt / equity
22.19×
This company
0.62×
Market median
-3479% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-07-22 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MI Chief Executive Officer | Chief Executive Officer | 2021 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 | |
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Antevski As
APOTEK 1 DVERGSNES AS Board members of APOTEK 1 DVERGSNES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Margarita Ivanova Antevska | Chief Executive Officer | 0 companies |